NEW BIOTIC, INC. – Trademark Portfolio

Entity Type: 03

NEW BIOTIC, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RAPHALX and RAPHAN+. The owner is based in Irvine, CA.

17901 Von Karman Ave., Suite 600

Irvine, CA 92614

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RAPHAN+
RAPHAN+
Registered 2022
RAPHAN+
RAPHAN+
Registered 2022
GLUTOX
GLUTOX
Abandoned 2019
RAPHALX
RAPHALX
Registered 2018

Trademark Classifications

NEW BIOTIC, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does NEW BIOTIC, INC. have?

NEW BIOTIC, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.

What trademark classes does NEW BIOTIC, INC. file in?

NEW BIOTIC, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NEW BIOTIC, INC.'s most well-known trademarks?

NEW BIOTIC, INC.'s registered trademark portfolio includes well-known marks such as RAPHALX and RAPHAN+. These are among 3 currently registered trademarks in the portfolio.

What is NEW BIOTIC, INC.'s trademark registration success rate?

NEW BIOTIC, INC. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.